ArrowDX

ArrowDx is creating precision diagnostics by combining AI and nanotechnology through a versatile, portable technology for a variety of applications.

[ArrowDX @ArrowDxInc]

In this interview, Arrow Dx Scientific Advisory Board member @sanjiv_chopra discusses non-alcoholic fatty liver disease (NAFLD) including current detection and treatment, and how Arrow Dx technology aims to help those with NAFLD with early detection.

https://t.co/1Iqlm7YUJO

[ArrowDX @ArrowDxInc]

Experience the challenging journey of patients like Danielle in navigating the diagnostic process for MASH.

Their stories shed light on the need for better tools and early detection. #MASLD #LiverHealth 🌟

[ArrowDX @ArrowDxInc]

3 reasons early liver disease detection matters:

Act before irreversible damage
Catch linked conditions like diabetes & obesity
Avoid invasive biopsies

Earlier detection = more options, better outcomes.
That’s what Arrow Dx is working toward.

[ArrowDX @ArrowDxInc]

Unveiling the Silent Threat: Fatty Liver Disease silently harms, often without symptoms. Early detection can change outcomes. Arrow Dx is on a mission to catch it early.

#FattyLiverAwareness #EarlyDetection

[ArrowDX @ArrowDxInc]

The conversation around MASH is changing fast. This progressive condition linked to metabolic dysfunction is a key player in liver health and patient management.

Learn more: https://t.co/wp490UrInz

[ArrowDX @ArrowDxInc]

Fatty liver disease often progresses silently, with many patients asymptomatic until advanced fibrosis.

Question for clinicians: How are you identifying liver disease risk earlier in practice?

[ArrowDX @ArrowDxInc]

Patients with type 2 diabetes have a significantly higher risk of fatty liver disease.

Earlier identification may allow clinicians to intervene sooner and improve long-term outcomes.

#MetabolicHealth #LiverDisease

[ArrowDX @ArrowDxInc]

Detecting fatty liver disease early can be challenging. Innovation in diagnostics may facilitate proactive strategies for improved intervention and outcomes. #LiverHealth #InnovationDetection

[ArrowDX @ArrowDxInc]

Behind every diagnosis is a human story.

Danielle’s journey with Stage 3 MASH highlights a major challenge in liver disease care: many patients face invasive procedures and delayed answers before receiving a diagnosis.

Read her story: https://t.co/QhkgRO7j00

[ArrowDX @ArrowDxInc]

MASLD/MASH care has evolved.

Fibrosis now drives decisions, noninvasive testing has largely replaced biopsy, and approved therapies are reshaping treatment.

Read more: https://t.co/UqeSycOCzn

#MASLD #MASH

[ArrowDX @ArrowDxInc]

Advancing patient care through precision diagnostics in metabolic liver disease and complex conditions by enabling proactive interventions and informed decision-making. #PrecisionMedicine #ImprovedPatientOutcomes

[ArrowDX @ArrowDxInc]

Identifying patients at-risk of advanced metabolic liver disease is crucial for optimal care. Learn more about enhancing clinical decision-making in liver health. #MASLD #MASH #LiverHealth

[ArrowDX @ArrowDxInc]

Meet Anmol Bajwa, our dedicated Business Development intern! A UC Berkeley student with a double major in Molecular & Cell Biology and Business, she's driving key growth initiatives at #ArrowDx this semester. 🌟 #InternshipImpact

[ArrowDX @ArrowDxInc]

Learn how understanding risk factors of liver disease like insulin resistance and obesity can make a difference in prevention. Early detection is crucial!

[ArrowDX @ArrowDxInc]

MAFLD is rising fast in young people. Global data shows 423M young adults were living with MAFLD in 2021 — a 75% increase since 1990. This underscores the need for earlier, scalable diagnostic detection. 🔗 https://t.co/tvsrvTvkQz

[ArrowDX @ArrowDxInc]

🔍 Embracing earlier detection, decentralized testing, adaptability, and accessibility are shaping the future of diagnostics. Arrow Dx is paving the way for impactful healthcare innovations. #Diagnostics #DiseaseDetection #MetabolicHealth #EarlyDetection

[ArrowDX @ArrowDxInc]

Unlocking the truth: High sensitivity diagnostics can be affordable and user-friendly.

Arrow Dx pioneers innovative solutions for accurate, accessible healthcare advancements. #Diagnostics #DiseaseDetection #MASLD #MASH #MetabolicHealth #LiverHealth #EarlyDetection

[ArrowDX @ArrowDxInc]

🌍 Making high-performance diagnostics more sustainable and affordable without sacrificing accuracy at Arrow Dx. Improving lives through early detection worldwide. #Diagnostics #ArrowDx #EarlyDetection

[ArrowDX @ArrowDxInc]

🔬 Arrow Dx's ultra-sensitive chips offer high sensitivity, versatile sample compatibility, and scalable design for widespread adoption in both healthcare and industry.

Discover how our platform enables earlier detectio: https://t.co/yJGsWEX7vI

[ArrowDX @ArrowDxInc]

🔬 Stay ahead in healthcare innovation with key diagnostics trends shaping the future.

Learn more about AI integration, point-of-care tools, and next-gen sensing technology: https://t.co/l47Zakfykv 🧠

[ArrowDX @ArrowDxInc]

Discover why early detection and expert guidance are crucial for combating rising cases of fatty liver disease worldwide.

Learn more from the Global Consensus Recommendations on MASLD and MASH: https://t.co/CcNI0eZzWV 🌍